Article

Clinical evaluation of deep learning-based risk profiling in breast cancer histopathology and comparison to an established multigene assay

2023-09-01

Abstract excerpt

<h4>ABSTRACT</h4> A significant proportion of oestrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative early breast cancer patients are categorised as intermediate risk based on classic clinicopathological variables, thus providing limited information to guide treatment decisions. The Prosigna assay is one of the established prognostic multigene assays in clinical practice for...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a5c07824-ba94-5f9c-ab7e-9bc37889ccec
DOI: 10.1101/2023.08.31.23294882

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical evaluation of deep learning-based risk profiling in breast cancer histopathology and comparison to an established multigene assayDOI 10.1101/2023.08.31.23294882Read

Clinical evaluation of deep learning-based risk profiling in breast cancer histopathology and comparison to an established multigene assaySemantic proximity Read

Deep Learning on Histopathological Images to Predict Breast Cancer Recurrence Risk and Chemotherapy BenefitSemantic proximity Read

Multi-stain modelling of histopathology slides for breast cancer prognosis predictionSemantic proximity Read

Deep learning framework for comprehensive molecular and prognostic stratifications of triple-negative breast cancerSemantic proximity Read

Predicting molecular subtypes of breast cancer using pathological images by deep convolutional neural network from public datasetSemantic proximity Read

Prediction of OncotypeDX recurrence score using H&E stained WSI imagesSemantic proximity Read

Clinical Validation of RlapsRisk BC in an international multi-cohorts settingSemantic proximity Read

Prognostic Risk Refinement using Artificial Intelligence in HR+/HER2- Early Breast Cancer: Implications for CDK4/6 Eligibility CriteriaSemantic proximity Read

Evaluation and comparison of different breast cancer prognosis scores based on gene expression dataSemantic proximity Read

Assessing the risk of recurrence in early-stage breast cancer through H&E stained whole slide imagesSemantic proximity Read

Development and Validation of a Multimodal Clinical, Pathologic, and Genomic Model for Breast Cancer RecurrenceSemantic proximity Read

End-to-End Integrative Segmentation and Radiomics Prognostic Models Improve Risk Stratification of High-Grade Serous Ovarian Cancer: A Retrospective Multi-Cohort StudySemantic proximity Read